| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| daunorubicin and cytarabine protocol | 1.51 | 1 | 3052 | 70 | 36 |
| daunorubicin | 1 | 1 | 8734 | 6 | 12 |
| and | 1.84 | 0.7 | 736 | 62 | 3 |
| cytarabine | 0.73 | 0.6 | 595 | 99 | 10 |
| protocol | 1.84 | 0.8 | 5932 | 50 | 8 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| daunorubicin-cytarabine | 0.12 | 0.4 | 4770 | 98 |
| daunorubicin and cytarabine liposome | 0.08 | 0.4 | 3723 | 38 |
| daunorubicin and cytarabine liposomal chemo | 2 | 0.7 | 181 | 31 |
| liposomal daunorubicin and cytarabine | 0.53 | 0.6 | 9438 | 17 |
| intermediate dose cytarabine protocol | 1.74 | 0.9 | 9423 | 20 |
| high dose cytarabine protocol | 0.29 | 0.5 | 6069 | 34 |
| low-dose cytarabine | 0.14 | 0.7 | 2524 | 99 |
| cytarabine mode of action | 0.52 | 0.8 | 5874 | 79 |
| cytarabine dose for cytoreduction | 1.66 | 0.5 | 1634 | 51 |
| cytarabine modality of action | 0.53 | 0.3 | 9356 | 76 |
| daunorubicin to doxorubicin conversion | 1.51 | 0.2 | 2984 | 2 |
| mechanism of action of daunorubicin | 1.73 | 0.6 | 9401 | 4 |
| liposomales daunorubicin und cytarabin | 1.71 | 0.5 | 9527 | 67 |
| how is daunorubicin administered | 1.05 | 0.4 | 9318 | 94 |
| daunorubicin-cytarabine liposome vyxeos | 1.91 | 0.2 | 2471 | 23 |
| cytarabine and daunorubicin | 1.92 | 0.8 | 8457 | 19 |
| cytarabine and daunorubicin liposome | 1.22 | 0.4 | 6073 | 39 |
| cytarabine daunorubicin midostaurin | 1.31 | 0.5 | 7608 | 69 |
| cytarabine and daunorubicin toxicity | 0.02 | 0.9 | 1894 | 75 |
| cytarabine daunorubicin liposomal | 1.7 | 0.8 | 346 | 20 |
